Rakesh Jhunjhunwala net worth surges by over 56% YoY or Rs 11000 cr in June 2022 quarter – know details here

The portfolio of billionaire investor Rakesh Jhunjhunwala surged over 56 per cent or Rs 11000 crore year-on-year (YoY) to Rs 30,680.8 crore in June quarter as of July 29, 2022, according to the stock analysis website trendlyne.com. 

The ace investor’s net portfolio worth in June 2021 quarter was over Rs. 19,615.1 crore with 38 stocks in his list, however, the stock count has come to 32 in June 2022 quarter. 

The major YoY difference in the net portfolio worth was mainly due to addition of two new stocks during December quarter – Star Health and Allied Insurance and Metro Brands, wherein the ace investor, who is also called a Big Bull of the Indian stock market, have added in his portfolio. 

He has 100,753,935 equity shares or 17.5 per cent stakes in Star Health, while 39,153,600 equity shares or 14.4 stakes in Metro Brands, as per the June shareholding pattern of the respective companies available on the BSE. 

Besides, other two favourite and most invested Tata Group company shares – Titan Company and Tata Motors are also the major contributor to Big Bull’s portfolio surge. Titan share price in the last one year as jumped almost 33 per cent and Tata Motors share price up nearly 53 per cent in a year. 

During the June 2022 quarter, the investor has mainly trimmed stakes from his portfolio stock, expect making re-entry in auto company Escorts Kubota, wherein bought 1,830,388 equity shares or 1.4 per cent stakes in the auto firm that is mainly involved in manufacturing agri-vehicles. 

Primarily, the celebrity investor has reduced at least 0.1 per cent stakes in five companies in June 2022 quarter, they are: Nazara Technologies, Tata Motors, Indiabulls Housing Finance, Autoline Industries, DB Realty, while he has cut about 0.2 per cent stakes in NCC limited during the quarter. 

A qualified Chartered Accountant, Rakesh Jhunjhunwala invests in both his own name and his wife Rekha Jhunjhunwala’s name. He also manages an asset firm Rare Enterprises and tends to favour stocks in the finance, tech, retail, and pharma sectors.